Investor Relations

(Security Code :4506 TSE Prime)

Pick Up

Feb. 02, 2026	Posted Conference on Q3 FY2025 Financial Results [Webcast]	Finances
Jan. 30, 2026	Presentation Material (Conference on Q3 FY2025 Financial Results)（PDF/741KB）	Finances
Jan. 30, 2026	Supplementary Financial Data (IFRS) for the Third Quarte of the Year Ending March 31, 2026（PDF/261KB）	Finances
Jan. 30, 2026	Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2025 [IFRS]（PDF/446KB）	Finances
Dec. 22, 2025	Sumitomo Pharma Selected as “Best Website” for the Third Consecutive Year in Both All Markets and Pharmaceuticals Sector Categories of Nikko Investor Relations’ FY2025 All-Listed-Companies Website Ranking	Others
Dec. 15, 2025	Sumitomo Pharma Selected as Highest Rating A-List Company by CDP for Two Consecutive Years in the Category of Climate Change in the CDP 2025	Sustainability

May 13, 2026	FY2025 financial results announcement (scheduled to be disclosed at 1:00 p.m.), conference on financial results FY2025 for Analysts, Investors, and the Press
Feb. 17, 2026	R&D Meeting